New HFEA Chief Executive announced
24 March 2010
Prof Lisa Jardine, Chair of the Human Fertilisation and Embryology Authority today announced that the Authority had appointed Alan Doran CB as its Chief Executive. Mr Doran has been interim Chief Executive since October 2007, on secondment from Department of Health.
Lisa Jardine said:
“It is great news that we have continuity of leadership at the Authority as we go into the first full year of our new legislation. There are challenging times ahead for all arms length bodies. I look forward enormously to working alongside Alan Doran, making sure that the HFEA goes on improving the quality of provision it gives to the sector.”
Alan Doran said:
“I could not be more delighted. The HFEA plays a truly singular role in society in regulating assisted conception services. Our members are a joy to work with and our staff are capable, talented and forgiving of their elders. I am looking forward to building on the enormous changes of the past few years with them all.”
Ends
Note to editors
- The interviews for the post of Chief Executive at HFEA were held in November 2009 and the announcement of the outcome awaited Treasury approval.
- The HFEA is the independent regulator for IVF treatment and embryo research. Our role is to protect patients and the public interest, to drive improvement in the treatment and research sectors and to provide information to the public and policymakers about treatment and research.
- The HFEA was set up in August 1991 as part of the Human Fertilisation and Embryology Act 1990. The HFEA’s principal tasks are to license and monitor clinics that carry out in vitro fertilisation (IVF), artificial insemination (AI) and human embryo research. The HFEA also regulates the storage of gametes (eggs and sperm) and embryos.
Page last updated: 24 March 2010